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ABSTRACT
The degradation of several high-molar-mass hyaluronan samples was investigated in the presence of ascorbic acid itself and further 
by an oxidative system composed of ascorbic acid plus transition metal ions, i.e. Fe(II) or Cu(II) ions. The latter oxidative system imitates 
conditions in a joint synovial fluid during early phase of acute joint inflammation and can be used as a model for monitoring oxidative 
degradation of hyaluronan under pathophysiological conditions. The system Cu(II) plus ascorbate (the Weissberger oxidative system) 
resulted in a more significant decrease of hyaluronan molar mass compared to the oxidative system Fe(II) plus ascorbate. Addition of 
manganese(II) chloride was found to decrease the rate of the oxidative damage of hyaluronan initiated by ascorbate itself and by the 
Weissberger system. 
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2Fe(II) + 2O2  2Fe(III) + 2O2
•– (redox reaction; reversible)  (1)
2O2
•– + 2H+  H2O2 + O2 (dismutation reaction)  (2)
----------------------------------------------
2Fe(II) + O2 + 2H+  2Fe(III) + H2O2  net reaction
----------------------------------------------
Fe(II) + H2O2  Fe(III) + •OH + HO– (Fenton reaction)  (3)
O2
•– + H2O2  HO• + HO– + O2 (Haber-Weiss reaction; reversible) (4)
LH + •OH  L• + H2O  (5)
L• + O2  LOO•  (6)
The LOO• radicals propagate the lipid peroxidation 
chain reactions LOO  + LH  LOOH + L•, and LOOH 
oxidizes ferrous ions yielding alkoxyl lipid radicals LOOH 
+ Fe(II)  LO• + Fe(III) + HO–, whereas the generated LO• 
radicals participate in the propagation phase of the lipid 
peroxidation reaction LO• + LH  LOH + L•.
Ascorbate (Asc–) belongs to the most efficient (bio)
reductants capable to keep iron ions in the lower oxida-
tion state and/or to recycle Fe(III) to Fe(II). The so-called 
iron-catalyzed ascorbate auto-oxidation yields an inter-
mediate – the semidehydroascorbate radical (Asc•–) – a 
low-reactive radical that can undergo dismutation/dispro-
portionation reaction to form Asc– and dehydroascorbate 
(DHA)
Introduction
Some biogenic transition metals, such as iron, copper, 
manganese, zinc, and cobalt, participate in the control of 
various metabolic and signaling pathways. However, their 
versatile coordination chemistry and redox properties 
allow them to escape the control mechanisms, such as 
homeostasis, transport, compartmentalization, and bind-
ing to the designated tissue and cell constituents (Valko et 
al., 2005; Šoltés and Kogan, 2009). 
In a wide variety of in vitro systems, Fe(II) salts and/
or non-enzyme complexed ferrous cations (e.g. Fe(II)-
EDTA) were shown to enhance oxygen radical damage by 
increasing the production of an oxidative species gener-
ally believed to be the hydroxyl free radical. Iron ions are 
known to cause peroxidation of (polyunsaturated) fatty 
acids in lipids (LH) and generate peroxyl lipid radicals 
(LOO•) by a sequence of the following reactions
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Asc– + Fe(III)  Asc•– + Fe(II)  (7)
2Asc•–  Asc– + DHA  (8)
Alternatively, complexes of Fe(II) ions and dioxygen 
are also assumed to yield reactive species of unknown 
nature, which are subsequently able to oxidize biological 
material (Qian and Buettner, 1999; Flemmig and Arnhold, 
2007).
A combination of ascorbate plus Cu(II) under 
aerobic conditions, the so-called Weissberger’s system 
(Weissberger et al., 1943; Khan and Martell, 1967), gives 
rise directly to hydrogen peroxide (cf. Scheme 1, Fisher 
and Naughton, 2003; 2004; 2005) and, taking into account 
the fact that ascorbate reduces Cu(II) to cuprous ions, it 
is feasible to assume that at copper-catalyzed ascorbate 
auto-oxidation, •OH radicals should be generated by a 
Fenton-type reaction Cu(I) + H2O2  Cu(II) + •OH + HO–. 
This conclusion was recently supported by an unambigu-
ous proof of production of hydroxyl radicals in a system 
comprising ascorbate plus CuCl2 by using EPR spin-trap 
technique, applying such spin traps as 5,5-dimethyl-1-pyr-
roline-N-oxide (DMPO) and 5-(diisopropoxyphosphoryl)-
5-methyl-1-pyrroline-N-oxide (DIPPMPO) (Šoltés et al., 
2006).
The oxidative damage of various biomolecules (lipids, 
enzymes, DNAs, etc.) with (catalytic) participation of 
inorganic Fe and/or Cu salts/complexes has been clearly 
demonstrated in many in vitro assays. Yet under physi-
ological conditions, taking into account the negligible 
availability of “free catalytic iron”, the significance of 
e.g. the Fenton reaction can not be fully clarified. The 
average-weight human body contains approximately 4–5 
g iron bound to hemoglobin, myoglobin, cytochromes, 
iron-containing enzymes, and to the iron storage pro-
teins – ferritin, transferrin, and hemosiderin. Similarly, 
about 95% of copper circulating in the blood is bound 
to ceruloplasmin. Further copper is bound/ligated to 
albumin, transcuprein, and CuZn-superoxide dismutase.
Unlike Fe and Cu, inorganic salts/complexes of the 
biogenic transition metal – Mn – are known to occur 
a t  h i g h  c o n c e n t r a t i o n s  i n  c e r t a i n  c e l l s .  A s  r e p o r t e d ,  
manganese concentrations in most adult human tissues 
range between 3 and 20 μM (Roth, 2006). The results of 
several in vitro studies imply that Mn in various forms 
does indeed inhibit damage mediated by •OH radicals, 
however only if their production is dependent on the 
presence of O2
•– or H2O2. Thus, Mn complexes appear 
to interact with  •OH, as well as with O2
•– and H2O2, in a 
fundamentally different fashion than those of Fe and Cu 
(Cheton and Archibald, 1988).
H y a l u r o n a n  ( H A ;  F i g u r e  1 )  i s  a  h i g h - m o l a r - m a s s  
glycosaminoglycan that has important functions in living 
organisms (Kogan et al., 2007; 2008). HA macromolecules 
with molar mass equaling several MDa are extruded into 
synovial fluid (SF) by synoviocytes/hyalocytes – the cells 
embedded in the synovial membrane. Free/non-associated 
HA present in SF determines its unique viscoelastic prop-
erties required for maintaining the proper functioning of 
the joints in vertebrates.
It is noteworthy that the half-life of HA in SF is only a 
few hours. Although the relatively fast HA catabolism is 
controlled by hyaluronidases in most tissues, in SF – due 
to the absence of these enzymes – different mechanisms 
are implemented in the rapid hyaluronan catabolism. One 
of the possible alternative mechanisms involved in the 
joints of healthy individuals is the oxidative/degradative 
action of reactive oxygen species (ROS) generated during 
the ascorbate auto-oxidation catalyzed by the transition 
metal (Fe and/or Cu) ions (Šoltés et al., 2005). Evidence 
exists that ROS are responsible for HA degradation in 
inflammatory joint diseases, such as osteoarthritis and 
rheumatoid arthritis (RA). HA involvement in activation 
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and modulation of the inflammatory response includes 
also its scavenging action toward ROS, such as •OH radi-
cals (Mendoza et al., 2007).
As demonstrated in many studies, under aerobic con-
ditions a ternary system, comprising HA macromolecules 
plus ascorbate and traces of iron or copper ions, induces 
gradual decrease of the viscosity of the HA solution, as 
a result of fragmentation/degradation of HA macromol-
ecules. However as to the effects of manganese on HA 
degradation invoked by ascorbate auto-oxidation, not 
a single study has been so far published. The impact of 
Mn(II) ions is stipulated by a known catalytic participa-
tion of this essential transition metal in the function of 
hyaluronan synthase(s) (Johnson et al., 2001; Weigel and 
DeAngelis, 2007).
As reported, certain Mn(II) complexes, including 
biologically relevant Mn(II) pyrophosphate and Mn(II) 
polyphosphate, can act as very effective antioxidants by 
indirectly suppressing or blocking •OH formation due 
to Fenton-, Haber-Weiss-, xanthinoxidase-Fe-EDTA-, or 
Fe(III)-H2O2-type reactions, precisely as do superoxide 
dismutase and catalase (Cheton and Archibald, 1988). It 
has been established that these two major antioxidatively 
acting enzymes are barely detectable in rheumatoid syno-
vial fluid (Wong et al., 1981; Parsons et al., 2002). Their 
levels in SF, if any, do not exceed 1 μg/mL and 50 ng/mL, 
respectively (McCord, 1974).
Potential use of manganous salts/complexes for pro-
tecting lipids against oxidative stress has been demon-
strated in several in vitro and in vivo studies (Cheton and 
Archibald, 1988; Shukla and Chandra, 1981; Archibald 
and Fridovich, 1982; Cavallini et al., 1984; Chang and 
Kosman, 1989; Varani et al., 1991; Coassin et al., 1992; 
Gray and Carmichael, 1992; Singh et al., 1992; Tampo and 
Yonaha, 1992; Sakurai et al., 1997; Sziraki et al., 1998; 1999; 
Hussain and Ali, 1999; Worley et al., 2002). The results 
reported indicate that Mn(II) scavenges superoxide anion 
radicals already at nanomolar concentrations, whereas 
its micromolar concentrations are required to scavenge 
hydroxyl radicals. Increasing concentrations of manga-
nese suppress lipid peroxidation even more strongly, and 
complete inhibition is reached at concentrations of 30 μM 
Mn(II) (Shukla and Chandra, 1981). 
Manganese may act as a chain-breaker in inhibiting 
iron-induced lipid peroxidation chain reactions (Sziraki 
et al., 1998; 1999), and as proposed (Coassin et al., 1992; 
Sziraki et al., 1998), Mn(II) may scavenge peroxyl lipid 
radicals via the following reaction 
LOO• + Mn(II) + H+  LOOH + Mn(III)   (9)
quenching in this way the propagation reactions of lipid 
peroxidation caused by hydroxyl radicals generated by 
pro-oxidative transition metals such as iron and copper. 
The aim of the present study was to investigate the 
function of trace concentrations of Fe(II), Cu(II), as well as 
of Mn(II) in ascorbate auto-oxidation, in which hyaluro-
nans of various molar masses are involved as indicators of 
pro- or antioxidative properties of the system.
Material and methods
Biopolymers
Six hyaluronan samples, covering by their molar-mass 
averages (Mw) the range of 0.43 to 1.3 MDa (cf. Table 1), 
were kindly donated by or purchased from the following 
HA manufacturers: Genzyme Corporation, Cambridge, 
MA, U.S.A; Sigma Chemicals Co., St. Louis, MO, U.S.A.; 
Lifecore Biomedical Inc., Chaska, MN, U.S.A.; and CPN 
Ltd., Ústí nad Orlicí, Czech Republic (Stankovská et al., 
2004, Šoltés et al., 2007). In the HA samples P9706-6 and 
P9710-2, the contents of the following (transition) metals 
were stated by manufacturer (in ppm): Fe = 27 and 13; Pb 
= 6 and 7; Cu = 3 and 4, respectively; Cr, Co, Ni < 3 and 
As, Cd, Hg < 1, in both samples [‘‘Certificate of Analysis’’ 
(Lifecore Biomedical Inc., Chaska, MN, U.S.A.)].
Chemicals 
Analytical purity grade NaCl and CuCl2·2H2O were 
from Slavus Ltd., Bratislava, Slovakia; FeCl2·4H2O was 
purchased from Penta CZ Ltd., Chrudim, Czech Republic; 
MnCl2·4H2O was from Lachema CZ Ltd., Brno, Czech 
Republic; ascorbic acid (AA) was from Merck KGaA, 
Darmstadt, Germany. Redistilled de-ionized quality 
grade water with ≤ 0.055 μS/cm conductivity was pre-
pared by using the TKA water purification system (Water 
Purification Systems GmbH, Niederelbert, Germany).
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Figure 1. Hyaluronan – the acid form.
Table 1. Summary of the characteristic parameters of the six HA 
samples.
Sample designation Parametera [unit]
Mw [kDa] Mw/Mn [–/–] Rg [nm]
B22157 1340 1.50 129.8
53H0439 1017 1.82 130.7
P9710-2Ab 808.7 1.63 110.0
P9706-6 803.9 1.64 107.9
CPN 659.4 1.88 97.4
1-9100-1 426.2 1.84 77.2
aMw – weight-average of molar masses, Mw/Mn – polydispersity index, and Rg – 
z-average of the radius of gyration.
bAged HA sample (Šoltés et al., 2007).29
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Hyaluronan degradation/Rotational viscometry
The HA sample (20 mg) was dissolved overnight in the 
dark in 0.15 M NaCl in two steps: First, 4.0 mL of the 
solvent was added in the morning. The next 3.95 mL of 
the solvent was added after 6 h. On the following morn-
ing, 50.0 μL of 16.0 mM AA dissolved in 0.15 M NaCl was 
added to the HA solution and blended for 30 s. The result-
ing solution (8 mL) containing HA (2.5 mg/mL) and AA 
(100 μM) was transferred into the Teflon® cup reservoir 
of the Brookfield LVDV-II+PRO rotational viscometer 
(Brookfield Engineering Labs., Inc., Middleboro, MA, 
U.S.A.). The recording of the viscometer output param-
eters started 2 min after the experiment onset. The solu-
tion dynamic viscosity (η) was measured at 25.0 ± 0.1 °C 
in 3 min intervals for up to 5 h. The viscometer Teflon® 
spindle rotated at 180 rpm, i.e. at the shear rate equaling 
237.6 s–1 (Šoltés et al., 2007).
When the effect of the addition of a single biogenic 
transition metal was investigated, the second portion of 
the aqueous NaCl solvent was only 3.90 mL. On the fol-
lowing morning, the addition of 50.0 μL of 16.0 mM AA to 
the HA solution was followed by the admixing of 50.0 μL 
of appropriate FeCl2, CuCl2, or MnCl2 solutions in 0.15 M 
aqueous NaCl. The concentration of the biogenic transi-
tion metal salt in the system was 0.5 or 5.0 μM when using 
FeCl2; 0.1, 1.0, or 5.0 μM with CuCl2; and 0.5 μM with 
MnCl2.
When the (inhibitory) action of the Mn(II) ions on HA 
degradation by the system comprising AA (100 μM) and 
CuCl2 (1.0 μM) was assessed, the second portion of aqueous 
NaCl was 3.85 mL. Fifty μL of the MnCl2 solution in 0.15 M 
aqueous NaCl was added to adjust the final Mn(II) con-
centration to 30 μM. Three different application schemes 
of AA and of the two metal ions were tested: (i) Mn(II) 
followed by (AA) and Cu(II); (ii) AA followed by Mn(II) 
and Cu(II); and (iii) Mn(II) followed by Cu(II) and AA.
In each case, a homogenous solution was obtained 
after 30 s of moderate stirring of the mixture upon addi-
tion of AA or transition metals. 
Under the above specified experimental settings, the 
torque values were in the interval between 82 and 23 %.
Results
As shown in Figure 2, left panel, the dynamic viscosity vs. 
time relationship of the solutions containing HA (2.5 mg/
mL) and AA (100 μM), with the exception of the two sam-
ples, namely CPN and 1-9100-1, indicates the presence of 
two distinct regions: (i) rheopectic and (ii) the region that 
should be assigned to the degradation of HA macromol-
ecules. As calculated from the Certificate of Analysis of 
the HA samples P9706-6 and P9710-2, solutions of these 
two samples contained the following concentrations of 
iron and copper ions: 1.209 and 0.118  μM (P9706-6) or 
0.582 and 0.157 μM (P9710-2), respectively. Due to the 
presence of these biogenic transition metal ions, the 
Fe(III)/Fe(II) and Cu(II)/Cu(I) catalyzed ascorbate auto-
oxidation leads to the generation of •OH radicals that, 
after a certain initiation period, promote degradation of 
HA macromolecules, which is manifested by a gradual 
decrease of the solution dynamic viscosity.
The results presented in Figure 2, right panel, indi-
cate that even a submicromolar addition of Mn(II) ions 
(0.5 μM) prolong the rheopectic region in the η vs. time 
plot up to 300 min, the total time of monitoring, which is 
especially recognizable in the case of the samples B22157, 
P9706-6, and P9710-2A. No or only small changes 
occurred using 0.5 μM Mn(II) ions with HA samples hav-
ing lower molar mass. It should be noted that most curves 
implied that a slight decrease in viscosity took place after 
addition of Mn(II).
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Figure 2. Time dependence of dynamic viscosity of HA solutions.
Left panel: Solutions of hyaluronan samples with addition of 100 μM AA. Right panel: Solutions of hyaluronan samples with addition of 100 μM AA 
and 0.5 μM MnCl2.30
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Contrary to an “antioxidative” action of MnCl2, an 
identical 0.5 μM concentration of FeCl2, or even smaller 
0.1 μM concentration of CuCl2 had a “pro-oxidative” 
effect on the degradation of HA macromolecules in most 
samples (compare the data presented in left and right 
panels in Figure 3 with those in Figure 2, left panel). The 
only exception was observed with the sample CPN, in 
which, however, a relatively high content of “a contami-
nant” – transition metal Mn ions – was detected (Prof. A. 
Staško, Slovak Technical University, Bratislava, Slovakia, 
personal communication).
The pro-oxidative effect of the addition of Fe or Cu ions 
is clearly indicated in a concentration-dependent manner 
(cf. Figure 4, left and right panels). A slight difference 
should be however pointed out concerning the “nominal” 
η2’ values, i.e. the values observed at the 2nd min after 
addition of metal ions in different concentrations (0.1 – 
5.0 μM) to the solutions containing HA (2.5 mg/mL) and 
AA (100 μM). For a better visualization, we shifted the 
η2’ value of the solutions containing metal salts to the 
value η2’ valid for the solutions comprising only HA and 
AA. By such “normalization”, the changes in the values of 
dynamic viscosity caused by different amounts of added 
FeCl2 and CuCl2 became more visible (as presented in 
both panels of Figure 4). As can be seen, the character of 
the time dependence of η value upon the addition of FeCl2 
can be described as a gradual monotonous concentration-
dependent decline, while the addition of CuCl2 resulted 
in a literally “dramatic” drop of η value in a very short 
time interval, after which its decrease continued, how-
ever at a much lower rate. A possible explanation of this 
dissimilarity may lie most probably in different reaction 
kinetics of the processes leading to generation of ROS 
in a system ascorbate plus FeCl2 and in that comprising 
ascorbate plus CuCl2.
The results presented in Figure 5 illustrate the effect of 
Mn(II) addition on η vs. time dependence of the solutions 
comprising high-molar-mass hyaluronan (2.5 mg/mL), 
ascorbate (100 μM), and CuCl2 (1.0 μM). The addition 
of MnCl2 i n  a  r e l a t i v e l y  h i g h  c o n c e n t r a t i o n  ( 3 0   μ M )  
resulted in a significant decrease of the degradation of 
HA macromolecules, however, none of the used applica-
tion schemes (i, ii, iii) resulted in total inhibition of the 
biopolymer degradation. While in the case of sample 
P9710-2A using the application scheme (iii), the sample 
damage was decreased to ca. 44% (cf. Figure 5, left panel), 
in the case of sample P9706-6, scheme (i) proved to be the 
most efficient, i.e. extent of degradation decreased to ca. 
39% (cf. Figure 5, right panel).
Discussion
Under physiological conditions as well as at the early 
stage of acute-phase joint inflammation, contribution of 
ascorbate auto-oxidation to the non-enzymatic catabo-
lism of high-molar-mass hyaluronan in SF is plausible 
since: (a) in a healthy human being, the content of free 
HA macromolecules in SF is 1.4–3.6 mg/mL (Kogan et al., 
2007); (b) the concentration of ascorbate in SF of healthy 
subjects reaches the values closely to those established in 
blood serum, i.e. 40–140 μM (Wong et al., 1981); (c) the 
total concentrations of Fe and Cu ions in SF of healthy 
human equal 5.2 and 4.3 μM, respectively, and they rise 
under pathological/inflammatory conditions such as 
osteoarthritis (OA) and RA; (d) in SF of the individuals 
suffering from RA, the total Cu concentration is increased 
more than three-fold compared to that of the healthy 
population (Niedermeier and Griggs, 1971) and their Cu 
concentration in SF ultrafiltrate equals 0.125 ± 0.095 μM 
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Figure 3. Time dependence of dynamic viscosity of HA solutions.
Left panel: Solutions of hyaluronan samples with addition of 100 μM AA and 0.5 μM FeCl2. Right panel: Solutions of hyaluronan samples with addition 
of 100 μM AA and 0.1 μM CuCl2.31
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(Naughton et al., 1995); (e) at ascorbate auto-oxidation 
with the catalytic contribution of Cu(II) traces, direct 
conversion/transformation of O2 to H2O2 takes place 
(Weissberger  et al., 1943; Khan and Martell, 1967; 
Fisher and Naughton 2003; 2004; 2005); (f) the average 
concentration of Mn ions in SF of healthy persons and 
patients with RA is relatively low (ca. 0.42 and 0.44 μM, 
respectively) (Niedermeier and Griggs, 1971).
Investigation of the participation of biogenic transi-
tion metals in oxidative damage of high-molar-mass HA 
appears to be very simple. However, at least two main 
technical/experimental obstacles should be pointed out. 
First: due to an extremely high aggressiveness of the oxi-
dative/radical processes, the materials, which come into 
contact with e.g. the •OH radicals, should be non-metallic 
(preferably made of glass or Teflon® (Stankovská et al., 
2004; 2005). Second: at present, such studies are substan-
tially limited due to the unavailability of the ultrapure 
HA reference preparations with sufficiently high molar 
masses completely devoid of contaminating metals.
The above limitations have been circumvented in our 
studies by using the Brookfield LVDV-II+PRO rotational 
viscometer equipped with a cup-reservoir and spindle both 
home-made of Teflon®, and by using HA samples which 
purity was sufficiently high. The samples coded P9706-6 
and P9710-2 with the known content of the given (transi-
tion) metals allowed us to calculate the concentrations of 
iron and copper ions in the solutions of these samples. 
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Figure 4. Time dependence of dynamic viscosity of HA P9710-2A (black lines) and P9706-6 (grey lines) sample solutions.
Left panel: Solutions of hyaluronan samples with addition of 100 μM AA and of 0.5 (1) or 5.0 μM (2) FeCl2. Right panel: Solutions of hyaluronan sam-
ples with addition of 100 μM AA and of 0.1 (1), 1.0 (2) or 5.0 μM (3) CuCl2.
Figure 5. Time dependence of dynamic viscosity of HA sample solutions P9710-2A (left panel) and P9706-6 (right panel) after addition of AA and 
CuCl2; (i) MnCl2 followed by AA and CuCl2; (ii) AA followed by MnCl2 and CuCl2; and (iii) MnCl2 followed by CuCl2 and AA. 
The concentrations used were 100 μM AA, 1.0 μM CuCl2, and 30 μM MnCl2.32
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The other four samples, despite their poor “identity” as 
concerns the content of metal impurities, were used since 
their mean molar masses covered a relatively broad range 
of 0.43 to 1.3 MDa (cf. Table 1).
Under the conditions used in our studies (neutral pH), 
the HA macromolecules are present in a highly ionized 
state: the pKa value for the d-glucuronic acid residues 
is 3.12 (Park and Chakrabarti, 1978). The d-glucuronic 
structural units of the HA polyanion form salts with 
transition metal counter-cations. As formerly reported 
(Nagy et al., 1998), HA is able to weakly bind cupric ions 
(the binding constant being 3.0 × 103 L/mol (Figueroa at 
al., 1977). Generally, the transition metal counter-cations 
form coordinate complex compounds, in which the metal 
cation can be fixed intra- or intermolecularly simply via 
the carboxyl groups of HA (Nagy et al., 1998; Pirc et al., 
2004). However , especially for the copper-hyaluronate 
coordinates, it has been suggested that in the metal ion 
“binding” site electrons of the nearest N-acetyl group 
from the same HA molecule might be involved along with 
the COO– group (Magnani et al., 1999).
The •OH radical, which redox potential (•OH/H2O) 
equals +2.31 V at pH 7, is classified as the most efficient 
initiator of the radical oxidation/degradation accepting an 
H• radical from the macromolecule of hyaluronan. The 
formation of •OH radicals can occur in several manners, 
while by far the most important in vivo mechanism is 
mediated by hydrogen peroxide. Under aerobic condi-
tions, its generation proceeds according to reactions 1 
and 2, as well as via those depicted in Scheme 1. Thus, on 
addition of a high excess of AA (100 μM), trace amounts 
(submicro/micro) of Fe and/or Cu ions present in the HA 
samples undergo multiple redox cycles generating a flux of 
•OH radicals. A “lag-phase” registered during the experi-
ments represented in Figure 2 (left panel) means that a 
given amount of initiating •OH radicals must be gener-
ated right at the beginning. An excess amount of either 
Fe or Cu ions added to the system comprising hyaluronan 
and ascorbate yields a much higher flux of •OH radicals 
(compare the results in Figs. 3 and 4 with those shown in 
Figure 2, left panel). The greater the metal content, the 
shorter or even absent is the lag-phase. Moreover, in the 
case of assessing the effect of CuCl2 added to the system 
(cf. Figure 4, right panel), a really dramatic decline in the 
η vs. time dependence can be observed for all HA sample 
solutions investigated.
The pro-oxidative effect of both biogenic transition 
metals, i.e. Fe and Cu, evidenced in the presented study 
corroborates the observations already published by sev-
eral authors studying HA degradation caused by ascorbate 
alone or in combination with Fe and/or Cu ions (Khan 
and Martell, 1967; Wong et al., 1981; Matsumura and 
Pigman, 1965; Niedermeier et al., 1967a; 1967b; Swann, 
1967; Halliwell and Foyer, 1976; Harris and Pigman, 
1976; Samuni et al., 1983; Buettner and Jurkiewicz, 1996). 
However, the study protocol including the assays of the 
effect of another biogenic transition metal, manganous 
ions, may to our knowledge be classified as pioneering. 
When added into the system comprising hyaluronan 
macromolecules, the reductant – ascorbate, and the 
pro-oxidatively acting Fe and/ or Cu ions, Mn(II) ions 
demonstrate a significant antioxidative effect. The high-
molar-mass HA samples were protected against degra-
dation by addition of a relatively low amount of MnCl2 
(0.5 μM; cf. Figure 2, right panel), i.e. one comparable to 
Mn contents in SF of healthy persons (0.42 μM on aver-
age) (Niedermeier and Griggs, 1971). On the other hand, 
in the case of a “massive” load of Cu(II) ions (1.0 μM), the 
added MnCl2 was also effective (cf. Figure 5, both panels), 
yet it should be pointed out that not even the highest 
concentration applied (30 μM) was able to prevent the 
oxidative damage of HA macromolecules.
The changes of the chemical structure of the HA chain 
occurring during the metal ions-catalyzed ascorbate auto-
oxidation with participation of manganous salts leading 
to the formation of an increased fraction of hyaluronan 
hydroperoxides (and/or of AOH-type derivatives) accord-
ing to the reactions 10 and 11 
AOO• + Mn(II) + H+  AOOH + Mn(III)   (10)
AO• + Mn(II) + H+  AOH + Mn(III)   (11)
analogously to reaction 9 suggested by Coassin et al. (1992) 
and Sziraki et al. (1998; 1999) have yet to be proven. The 
hyaluronan hydroperoxides produced in this way should, 
however, be decomposed by the action of the two transition 
metal cations in lower oxidation states – Cu(I) and Fe(II).
For detection of such AOOH and/or AOH type 
derivatives, the non-isothermal chemiluminometry and 
MALDI-TOF mass spectrometry could be proposed as 
relevant analytical methods (Šoltés et al., 2006; 2007; 
Rychlý et al., 2006).
Concluding Remarks
The structure of the electronic orbitals of iron – 1s22s22p-
63s23p63d64s2 – and its high redox potential value – 
Fe(III)/Fe(II) equaling +0.48 V at pH 7 (Koppenol, 1994) 
– predetermine iron as one of the major participants in 
the production (and metabolism) of free radicals in bio-
logical systems. While Fe(III) at physiological pH values 
precipitates as oxyhydroxide aggregates, compounds 
containing Fe(II) are soluble, though unstable, and tend 
to react with oxygen to form superoxide anion radical 
(O2
•–) and Fe(III). Yet the biological reductant present in 
the system, i.e. ascorbate (Asc–), restores iron’s lower oxi-
dation state according to reaction 7. Thus, the so-called 
“auto-oxidation” of ascorbate is actually mediated by trace 
amounts of transition metals, such as iron (Buettner and 
Jurkiewicz, 1993). In any case, it should be pointed out 
that the biological consequences of the interaction of 
ascorbate (vitamin C) with iron are not yet fully under-
stood. Over the past decades, the pro-oxidant properties 
of ascorbate have also been investigated, in addition to its 
better explored antioxidant role. 
The copper electron configuration is 1s22s22p-
63s23p63d104s1 and the value of its redox potential 33
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Cu(II)/Cu(I) is +0.16 V at pH  7. The bivalent Cu(II) is 
paramagnetic (3d9) and represents the most stable oxida-
tion state of copper. Ceruloplasmin carries copper atoms 
in both Cu(II) and Cu(I) states. However, it has been 
demonstrated that a fraction of loosely bound copper may 
be “liberated” under certain circumstances. Moreover, 
reactive oxygen species appear to disrupt copper binding 
to ceruloplasmin, thereby impairing its normal protective 
function while releasing free copper, which in turn may 
promote oxidative pathology (Shukla et al., 2006). Since 
ascorbate acts as a powerful reducing agent with a redox 
potential of +0.282 V for the redox couple Asc•–/Asc– at 
pH 7, it should reduce Cu(II) to Cu(I) and hence cuprous 
ions should be able to reduce molecules of dioxygen 
directly to H2O2.
The human body contains about 300 ppm of man-
ganese; the recommended daily intake of this essential 
element is 3–9 mg. The Mn electron configuration is 
1s22s22p63s23p63d54s2 and the Mn(III)/Mn(II) redox 
potential equals +1.5 V at pH 7. Manganese exists in sev-
eral different oxidation states; within biological systems, 
however, the +2 valence prevails (Roth, 2006). Manganous 
ions are paramagnetic and thus detectable by EPR spec-
troscopy. The six-band EPR spectrum of Mn(II) has been 
detected in most natural (bio)products. A sub-ppm/ppm 
concentration of Mn in HA samples is an established fact, 
which should be taken into account at performing experi-
ments (Prof. V. Brezová, Slovak Technical University, 
Bratislava, Slovakia, personal communication).
Various carbohydrate-based preparations with 
specifically designed precise structures and molecular 
parameters are currently believed to be the future effec-
tive tools/remedies applicable at treating a number of 
diseases (Volpi, 2006). So-called viscosupplementing 
injections of high-molar-mass hyaluronan directly into 
the osteoarthritic joints could be classified as one of such 
examples. A further step forward could be elimination or 
minimalization of the content of Fe and Cu and a poten-
tially advantageous addition of an appropriate Mn(II) salt/
complex to the injection mixtures to be administered at 
viscosupplementary treatment of OA.
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